Loading...

Nynikka Palmer, DrPH, MPH

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Texas Health Science CenterDrPH2010School of Public Health
    Emory UniversityMPH2002Rollins School of Public Health
    Morgan State UniversityBS2000
    Collapse Awards and Honors
    University of California San Francisco2018School of Medicine Inaugural Class of Dean’s Population Health and Healthy Equity (PHHE) Scholars
    National Institutes of Health – National Institute on Minority Health and Health Disparities2016  - 2017Health Disparities Research Loan Repayment Program
    University of California San Francisco2016  - 2017CTSI KL2 Scholar Award
    University of California San Francisco2016Helen Diller Family Chair in Community Education and Outreach for Urologic Cancer
    University of California San Francisco2015  - 2016Center for Aging in Diverse Communities Scholar Award
    University of California San Francisco2015Distinguished Honoree of the Black Student Health Alliance - 2nd Annual African Heritage Celebration
    National Institute on Minority Health and Health Disparities - National Institutes of Health2013  - 2015Health Disparities Research Loan Repayment Program
    University of Texas Health Science Center at Houston, School of Public Health2010Doctoral Dissertation Research Award
    American Cancer Society2004Excellence in Community Outreach
    Minority Training Program in Cancer Control Research, Northern California Cancer Center2003Doctoral Application Support Award

    Collapse Overview 
    Collapse Overview
    Dr. Nynikka Palmer received her undergraduate training from Morgan State University, where she obtained a degree in health education with honors. She then earned a master’s degree in public health from Emory University’s Rollins School of Public Health and subsequently worked for 3 years at the American Cancer Society in Atlanta, Georgia collaborating with community organizations on cancer education and early detection in minority and underserved communities. Dr. Palmer then earned a doctorate in public health, in behavioral sciences and health promotion from the University of Texas, School of Public Health in Houston. During her doctoral program, she was a pre-doctoral fellow in an NCI-sponsored cancer prevention and control training program. She extended her training in cancer with a focus on cancer survivorship and health disparities as a postdoctoral fellow on an NCI-sponsored training award at Wake Forest School of Medicine. Dr. Palmer was recruited to join the faculty at UCSF in 2013 to further establish her research in cancer health disparities. Currently, she is an Assistant Professor, with a primary appointment in the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFGH) and secondary appointments in Urology and Radiation Oncology. Dr. Palmer is also an Associate member of the UCSF Helen Diller Family Comprehensive Cancer Center and an Associate Faculty member of the Center for Vulnerable Populations at ZSFGH.

    Dr. Palmer’s research is grounded in cancer disparities and has progressed over the years to focus on racial/ethnic and geographic disparities (e.g., rural/urban) in cancer, challenges faced by male cancer survivors, prostate cancer in African American men, and quality cancer care. During her postdoctoral fellowship, she examined racial/ethnic disparities in health care receipt among male cancer survivors, rural/urban disparities in cancer survivors forgoing care because of cost, and racial/ethnic disparities in patient-provider communication, quality of care ratings, and patient activation among long-term cancer survivors. Dr. Palmer is particularly interested in prostate cancer among African American men, and has examined African American prostate cancer survivors’ treatment decision-making and their subsequent quality of life. Findings from these studies have directed her research agenda to further understand and examine quality of care and patient-provider communication among African American men with prostate cancer, particularly in low-income communities. Dr. Palmer’s long-term goal is to move beyond identifying cancer disparities to developing, implementing, and disseminating interventions and programs that will ultimately reduce the burden of cancer among vulnerable populations.

    Collapse Research 
    Collapse Research Activities and Funding
    Accelerating Systematic Stakeholder, Patient, and Institution Research Engagement (ASPIRE)
    PCORI – Patient-Centered Outcomes Research Institute 10566-UCSFOct 2, 2018 - Oct 1, 2020
    Role: Program Development and Evaluation
    Constructing a Relational Bridge to Achieve High-Quality Prostate Cancer Care for African Americans
    NIH K01CA211965Sep 1, 2017 - Aug 31, 2022
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kith G, Lisker S, Sarkar U, Barr-Walker J, Breyer BN, Palmer NR. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review. Eur Urol Oncol. 2019 Jul 06. PMID: 31288992.
      View in: PubMed
    2. Balakrishnan AS, Palmer NR, Fergus KB, Gaither TW, Baradaran N, Ndoye M, Breyer BN. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement. J Urol. 2019 02; 201(2):259-267. PMID: 30218761.
      View in: PubMed
    3. Borno HT, Lichtensztajn DY, Gomez SL, Palmer NR, Ryan CJ. Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer. Cancer. 2019 Feb 01; 125(3):453-462. PMID: 30444526.
      View in: PubMed
    4. Kaplan CP, Siegel A, Leykin Y, Palmer NR, Borno H, Bielenberg J, Livaudais-Toman J, Ryan C, Small EJ. A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy. Contemp Clin Trials Commun. 2018 Dec; 12:60-67. PMID: 30272035.
      View in: PubMed
    5. Palmer NR, Gregorich SE, Livaudais-Toman J, Jih J, Kaplan CP. Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making. J Racial Ethn Health Disparities. 2018 Dec; 5(6):1273-1283. PMID: 29516434.
      View in: PubMed
    6. Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, Palmer N, Perkins A, Potter MB, Somsouk M, Vargas RA, van 't Veer LJ, Ashworth A. The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. Health Aff (Millwood). 2018 01; 37(1):54-61. PMID: 29309234.
      View in: PubMed
    7. Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative. BMC Cancer. 2017 12 13; 17(1):848. PMID: 29237415.
      View in: PubMed
    8. Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. Urol Oncol. 2017 11; 35(11):663.e9-663.e14. PMID: 28826701.
      View in: PubMed
    9. Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM. Disparities in barriers to follow-up care between African American and White breast cancer survivors. Support Care Cancer. 2015 Nov; 23(11):3201-9. PMID: 25821145; PMCID: PMC4586316 [Available on 11/01/16].
    10. Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 2015 Apr 15; 121(8):1265-72. PMID: 25754547.
      View in: PubMed
    11. Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, Blanch-Hartigan D, Oakley-Girvan I, Hamilton AS, Weaver KE. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. J Clin Oncol. 2014 Dec 20; 32(36):4087-94. PMID: 25403220.
      View in: PubMed
    12. Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE. Impact of rural residence on forgoing healthcare after cancer because of cost. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1668-76. PMID: 24097196; PMCID: PMC3833446.
    13. Palmer NR, Geiger AM, Felder TM, Lu L, Case LD, Weaver KE. Racial/Ethnic disparities in health care receipt among male cancer survivors. Am J Public Health. 2013 Jul; 103(7):1306-13. PMID: 23678936.
      View in: PubMed
    14. Weaver KE, Palmer N, Lu L, Case LD, Geiger AM. Rural-urban differences in health behaviors and implications for health status among US cancer survivors. Cancer Causes Control. 2013 Aug; 24(8):1481-90. PMID: 23677333.
      View in: PubMed
    15. Palmer NR, Bartholomew LK, McCurdy SA, Basen-Engquist KM, Naik AD. Transitioning from active treatment: colorectal cancer survivors' health promotion goals. Palliat Support Care. 2013 Apr; 11(2):101-9. PMID: 23089464; PMCID: PMC3615141.
    16. Palmer NR, Tooze JA, Turner AR, Xu J, Avis NE. African American prostate cancer survivors' treatment decision-making and quality of life. Patient Educ Couns. 2013 Jan; 90(1):61-8. PMID: 22940374; PMCID: PMC3536017.
    17. Naik AD, Palmer N, Petersen NJ, Street RL, Rao R, Suarez-Almazor M, Haidet P. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med. 2011 Mar 14; 171(5):453-9. PMID: 21403042.
      View in: PubMed
    18. Felder TM, Palmer NR, Lal LS, Mullen PD. What is the evidence for pharmaceutical patient assistance programs? A systematic review. J Health Care Poor Underserved. 2011 Feb; 22(1):24-49. PMID: 21317504.
      View in: PubMed